Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 41 entries
Sorted by: Best Match Show Resources per page
Halogen-bond-based cooperative ion-pair recognition by a crown-ether-embedded 5-iodo-1,2,3-triazole.

Chemical communications (Cambridge, England)

Tepper R, Schulze B, Bellstedt P, Heidler J, Görls H, Jäger M, Schubert US.
PMID: 28150008
Chem Commun (Camb). 2017 Feb 14;53(14):2260-2263. doi: 10.1039/c6cc09749a.

A crown-ether containing the iodo-triazole moiety for simultaneous cation-anion binding through Lewis-basic nitrogen atoms and C-II halogen-bond-donating iodine atoms was prepared. The complexation of the heteroditopic receptor was illustrated by X-ray and DFT analysis. The cooperative effect boosting the...

Cite
Tepper R, Schulze B, Bellstedt P, et al. Halogen-bond-based cooperative ion-pair recognition by a crown-ether-embedded 5-iodo-1,2,3-triazole. Chem Commun (Camb). 2017;53(14):2260-2263doi: 10.1039/c6cc09749a.
Tepper, R., Schulze, B., Bellstedt, P., Heidler, J., Görls, H., Jäger, M., & Schubert, U. S. (2017). Halogen-bond-based cooperative ion-pair recognition by a crown-ether-embedded 5-iodo-1,2,3-triazole. Chemical communications (Cambridge, England), 53(14), 2260-2263. https://doi.org/10.1039/c6cc09749a
Tepper, Ronny, et al. "Halogen-bond-based cooperative ion-pair recognition by a crown-ether-embedded 5-iodo-1,2,3-triazole." Chemical communications (Cambridge, England) vol. 53,14 (2017): 2260-2263. doi: https://doi.org/10.1039/c6cc09749a
Tepper R, Schulze B, Bellstedt P, Heidler J, Görls H, Jäger M, Schubert US. Halogen-bond-based cooperative ion-pair recognition by a crown-ether-embedded 5-iodo-1,2,3-triazole. Chem Commun (Camb). 2017 Feb 14;53(14):2260-2263. doi: 10.1039/c6cc09749a. PMID: 28150008.
Copy Download .nbib Format: NLM
Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37].

Leukemia research

Garcia C, Rosén A, Kimby E, Aguilar-Santelises M, Jondal M, Björkholm M, Holm G, Mellstedt H.
PMID: 28314441
Leuk Res. 2017 Jun;57:127. doi: 10.1016/j.leukres.2017.01.029. Epub 2017 Mar 15.

No abstract available.

Cite
Garcia C, Rosén A, Kimby E, et al. Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37]. Leuk Res. 2017;57:127doi: 10.1016/j.leukres.2017.01.029.
Garcia, C., Rosén, A., Kimby, E., Aguilar-Santelises, M., Jondal, M., Björkholm, M., Holm, G., & Mellstedt, H. (2017). Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37]. Leukemia research, 57127. https://doi.org/10.1016/j.leukres.2017.01.029
Garcia, C, et al. "Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37]." Leukemia research vol. 57 (2017): 127. doi: https://doi.org/10.1016/j.leukres.2017.01.029
Garcia C, Rosén A, Kimby E, Aguilar-Santelises M, Jondal M, Björkholm M, Holm G, Mellstedt H. Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37]. Leuk Res. 2017 Jun;57:127. doi: 10.1016/j.leukres.2017.01.029. Epub 2017 Mar 15. PMID: 28314441.
Copy Download .nbib Format: NLM
Clinical considerations for biosimilar antibodies.

EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]

Mellstedt H.
PMID: 26217160
EJC Suppl. 2013 Dec;11(3):1-11. doi: 10.1016/S1359-6349(13)70001-6.

Biosimilar agents are approximate copies of branded biologic therapies. Since the first biosimilar was authorized in the European Union in 2006, fifteen additional agents have been approved by the European Medicines Agency, including two biosimilar monoclonal antibodies (mAbs). Biosimilar...

Cite
Mellstedt H. Clinical considerations for biosimilar antibodies. EJC Suppl. 2013;11(3):1-11doi: 10.1016/S1359-6349(13)70001-6.
Mellstedt, H. (2013). Clinical considerations for biosimilar antibodies. EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.], 11(3), 1-11. https://doi.org/10.1016/S1359-6349(13)70001-6
Mellstedt, Håkan. "Clinical considerations for biosimilar antibodies." EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.] vol. 11,3 (2013): 1-11. doi: https://doi.org/10.1016/S1359-6349(13)70001-6
Mellstedt H. Clinical considerations for biosimilar antibodies. EJC Suppl. 2013 Dec;11(3):1-11. doi: 10.1016/S1359-6349(13)70001-6. PMID: 26217160; PMCID: PMC4048039.
Copy Download .nbib Format: NLM
Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells.

Experimental hematology & oncology

Mikaelsson E, Osterborg A, Tahmasebi Fard Z, Mahmoudi A, Mahmoudian J, Jeddi-Tehrani M, Akhondi M, Shokri F, Bishop PN, Rabbani H, Mellstedt H.
PMID: 24499526
Exp Hematol Oncol. 2013 Aug 28;2(1):23. doi: 10.1186/2162-3619-2-23.

BACKGROUND: Opticin (OPTC) is a member of the small leucine-rich proteoglycan (SLRP) family and is localized particularly in certain extracellular matrices. We have previously reported the unique expression of another SLRP, fibromodulin (FMOD) in the leukemic cells of patients...

Cite
Mikaelsson E, Osterborg A, Tahmasebi Fard Z, et al. Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells. Exp Hematol Oncol. 2013;2(1):23doi: 10.1186/2162-3619-2-23.
Mikaelsson, E., Osterborg, A., Tahmasebi Fard, Z., Mahmoudi, A., Mahmoudian, J., Jeddi-Tehrani, M., Akhondi, M., Shokri, F., Bishop, P. N., Rabbani, H., & Mellstedt, H. (2013). Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells. Experimental hematology & oncology, 2(1), 23. https://doi.org/10.1186/2162-3619-2-23
Mikaelsson, Eva, et al. "Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells." Experimental hematology & oncology vol. 2,1 (2013): 23. doi: https://doi.org/10.1186/2162-3619-2-23
Mikaelsson E, Osterborg A, Tahmasebi Fard Z, Mahmoudi A, Mahmoudian J, Jeddi-Tehrani M, Akhondi M, Shokri F, Bishop PN, Rabbani H, Mellstedt H. Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells. Exp Hematol Oncol. 2013 Aug 28;2(1):23. doi: 10.1186/2162-3619-2-23. PMID: 24499526; PMCID: PMC3766095.
Copy Download .nbib Format: NLM
Cell-Based Kinetic Target-Guided Synthesis of an Enzyme Inhibitor.

ACS medicinal chemistry letters

Antti H, Sellstedt M.
PMID: 29670699
ACS Med Chem Lett. 2018 Mar 08;9(4):351-353. doi: 10.1021/acsmedchemlett.7b00535. eCollection 2018 Apr 12.

Finding a new drug candidate for a selected target is an expensive and time-consuming process. Target guided-synthesis, or

Cite
Antti H, Sellstedt M. Cell-Based Kinetic Target-Guided Synthesis of an Enzyme Inhibitor. ACS Med Chem Lett. 2018;9(4):351-353doi: 10.1021/acsmedchemlett.7b00535.
Antti, H., & Sellstedt, M. (2018). Cell-Based Kinetic Target-Guided Synthesis of an Enzyme Inhibitor. ACS medicinal chemistry letters, 9(4), 351-353. https://doi.org/10.1021/acsmedchemlett.7b00535
Antti, Henrik, and Sellstedt, Magnus. "Cell-Based Kinetic Target-Guided Synthesis of an Enzyme Inhibitor." ACS medicinal chemistry letters vol. 9,4 (2018): 351-353. doi: https://doi.org/10.1021/acsmedchemlett.7b00535
Antti H, Sellstedt M. Cell-Based Kinetic Target-Guided Synthesis of an Enzyme Inhibitor. ACS Med Chem Lett. 2018 Mar 08;9(4):351-353. doi: 10.1021/acsmedchemlett.7b00535. eCollection 2018 Apr 12. PMID: 29670699; PMCID: PMC5900323.
Copy Download .nbib Format: NLM
ESMO's new strategic plan: our society's road to the future of oncology.

Annals of oncology : official journal of the European Society for Medical Oncology

Baselga J, Mellsted H, Kerr D.
PMID: 32560010
Ann Oncol. 2009 Jan;20(1):3-4. doi: 10.1093/annonc/mdn780. Epub 2019 Dec 04.

No abstract available.

Cite
Baselga J, Mellsted H, Kerr D. ESMO's new strategic plan: our society's road to the future of oncology. Ann Oncol. 2019;20(1):3-4doi: 10.1093/annonc/mdn780.
Baselga, J., Mellsted, H., & Kerr, D. (2009). ESMO's new strategic plan: our society's road to the future of oncology. Annals of oncology : official journal of the European Society for Medical Oncology, 20(1), 3-4. https://doi.org/10.1093/annonc/mdn780
Baselga, J, et al. "ESMO's new strategic plan: our society's road to the future of oncology." Annals of oncology : official journal of the European Society for Medical Oncology vol. 20,1 (2009): 3-4. doi: https://doi.org/10.1093/annonc/mdn780
Baselga J, Mellsted H, Kerr D. ESMO's new strategic plan: our society's road to the future of oncology. Ann Oncol. 2009 Jan;20(1):3-4. doi: 10.1093/annonc/mdn780. Epub 2019 Dec 04. PMID: 32560010.
Copy Download .nbib Format: NLM
A microstructured p-Si photocathode outcompetes Pt as a counter electrode to hematite in photoelectrochemical water splitting.

Dalton transactions (Cambridge, England : 2003)

Kawde A, Annamalai A, Sellstedt A, Glatzel P, Wågberg T, Messinger J.
PMID: 30534760
Dalton Trans. 2019 Jan 22;48(4):1166-1170. doi: 10.1039/c8dt03653e.

Herein, we communicate about an Earth-abundant semiconductor photocathode (p-Si/TiO2/NiOx) as an alternative for the rare and expensive Pt as a counter electrode for overall photoelectrochemical water splitting. The proposed photoelectrochemical (PEC) water-splitting device mimics the "Z"-scheme observed in natural...

Cite
Kawde A, Annamalai A, Sellstedt A, et al. A microstructured p-Si photocathode outcompetes Pt as a counter electrode to hematite in photoelectrochemical water splitting. Dalton Trans. 2019;48(4):1166-1170doi: 10.1039/c8dt03653e.
Kawde, A., Annamalai, A., Sellstedt, A., Glatzel, P., Wågberg, T., & Messinger, J. (2019). A microstructured p-Si photocathode outcompetes Pt as a counter electrode to hematite in photoelectrochemical water splitting. Dalton transactions (Cambridge, England : 2003), 48(4), 1166-1170. https://doi.org/10.1039/c8dt03653e
Kawde, Anurag, et al. "A microstructured p-Si photocathode outcompetes Pt as a counter electrode to hematite in photoelectrochemical water splitting." Dalton transactions (Cambridge, England : 2003) vol. 48,4 (2019): 1166-1170. doi: https://doi.org/10.1039/c8dt03653e
Kawde A, Annamalai A, Sellstedt A, Glatzel P, Wågberg T, Messinger J. A microstructured p-Si photocathode outcompetes Pt as a counter electrode to hematite in photoelectrochemical water splitting. Dalton Trans. 2019 Jan 22;48(4):1166-1170. doi: 10.1039/c8dt03653e. PMID: 30534760.
Copy Download .nbib Format: NLM
Introduction: ASCO-ESMO consensus statement on quality cancer care.

Annals of oncology : official journal of the European Society for Medical Oncology

Horning SJ, Mellstedt H.
PMID: 32521588
Ann Oncol. 2006 Jul;17(7):1061. doi: 10.1093/annonc/mdl164. Epub 2019 Dec 10.

No abstract available.

Cite
Horning SJ, Mellstedt H. Introduction: ASCO-ESMO consensus statement on quality cancer care. Ann Oncol. 2019;17(7):1061doi: 10.1093/annonc/mdl164.
Horning, S. J., & Mellstedt, H. (2006). Introduction: ASCO-ESMO consensus statement on quality cancer care. Annals of oncology : official journal of the European Society for Medical Oncology, 17(7), 1061. https://doi.org/10.1093/annonc/mdl164
Horning, S J, and Mellstedt, H. "Introduction: ASCO-ESMO consensus statement on quality cancer care." Annals of oncology : official journal of the European Society for Medical Oncology vol. 17,7 (2006): 1061. doi: https://doi.org/10.1093/annonc/mdl164
Horning SJ, Mellstedt H. Introduction: ASCO-ESMO consensus statement on quality cancer care. Ann Oncol. 2006 Jul;17(7):1061. doi: 10.1093/annonc/mdl164. Epub 2019 Dec 10. PMID: 32521588.
Copy Download .nbib Format: NLM
Unravelling the dissolution mechanism of polyphosphate glasses by .

Dalton transactions (Cambridge, England : 2003)

Avila Salazar DA, Bellstedt P, Miura A, Oi Y, Kasuga T, Brauer DS.
PMID: 33646216
Dalton Trans. 2021 Mar 21;50(11):3966-3978. doi: 10.1039/d0dt03381b. Epub 2021 Mar 01.

Phosphate glass dissolution can be tailored via compositional and subsequent structural changes, which is of interest for biomedical applications such as therapeutic ion delivery. Here, solid-state

Cite
Avila Salazar DA, Bellstedt P, Miura A, et al. Unravelling the dissolution mechanism of polyphosphate glasses by . Dalton Trans. 2021;50(11):3966-3978doi: 10.1039/d0dt03381b.
Avila Salazar, D. A., Bellstedt, P., Miura, A., Oi, Y., Kasuga, T., & Brauer, D. S. (2021). Unravelling the dissolution mechanism of polyphosphate glasses by . Dalton transactions (Cambridge, England : 2003), 50(11), 3966-3978. https://doi.org/10.1039/d0dt03381b
Avila Salazar, Dahiana A, et al. "Unravelling the dissolution mechanism of polyphosphate glasses by ." Dalton transactions (Cambridge, England : 2003) vol. 50,11 (2021): 3966-3978. doi: https://doi.org/10.1039/d0dt03381b
Avila Salazar DA, Bellstedt P, Miura A, Oi Y, Kasuga T, Brauer DS. Unravelling the dissolution mechanism of polyphosphate glasses by . Dalton Trans. 2021 Mar 21;50(11):3966-3978. doi: 10.1039/d0dt03381b. Epub 2021 Mar 01. PMID: 33646216.
Copy Download .nbib Format: NLM
Fine-Needle Aspiration Cytology with Immunocytochemistry of Extranodal Manifestations of Non-Hodgkin's Lymphoma.

Leukemia & lymphoma

Tani E, Liliemark J, Biberfelds P, Johanssons B, Mellstedt H, Skoog L.
PMID: 27463819
Leuk Lymphoma. 1990;1(2):129-39. doi: 10.3109/10428199009042470.

Sixty-three patients with extranodal manifestations of non-Hodgkin's lymphoma were examined with fine-needle aspiration cytology and diagnosed according to the Kiel classification. Cytospin preparations were made from the aspirates and used for immunocytochemical analysis. Primary extranodal manifestations were found in...

Cite
Tani E, Liliemark J, Biberfelds P, et al. Fine-Needle Aspiration Cytology with Immunocytochemistry of Extranodal Manifestations of Non-Hodgkin's Lymphoma. Leuk Lymphoma. 1990;1(2):129-39doi: 10.3109/10428199009042470.
Tani, E., Liliemark, J., Biberfelds, P., Johanssons, B., Mellstedt, H., & Skoog, L. (1990). Fine-Needle Aspiration Cytology with Immunocytochemistry of Extranodal Manifestations of Non-Hodgkin's Lymphoma. Leukemia & lymphoma, 1(2), 129-39. https://doi.org/10.3109/10428199009042470
Tani, E, et al. "Fine-Needle Aspiration Cytology with Immunocytochemistry of Extranodal Manifestations of Non-Hodgkin's Lymphoma." Leukemia & lymphoma vol. 1,2 (1990): 129-39. doi: https://doi.org/10.3109/10428199009042470
Tani E, Liliemark J, Biberfelds P, Johanssons B, Mellstedt H, Skoog L. Fine-Needle Aspiration Cytology with Immunocytochemistry of Extranodal Manifestations of Non-Hodgkin's Lymphoma. Leuk Lymphoma. 1990;1(2):129-39. doi: 10.3109/10428199009042470. PMID: 27463819.
Copy Download .nbib Format: NLM
Ammonium effects on function and structure of nitrogen-fixing root nodules of Alnus incana (L.) Moench.

Planta

Huss-Danell K, Sellstedt A, Flower-Ellis A, Sjöström M.
PMID: 24272578
Planta. 1982 Dec;156(4):332-40. doi: 10.1007/BF00397471.

Cloned plants of Alnus incana (L.) Moench were inoculated and grown without combined nitrogen for seven weeks. The effects of ammonium on the function and structure of the root nodules were studied by adding 20 mM NH4Cl (20 mM...

Cite
Huss-Danell K, Sellstedt A, Flower-Ellis A, et al. Ammonium effects on function and structure of nitrogen-fixing root nodules of Alnus incana (L.) Moench. Planta. 1982;156(4):332-40doi: 10.1007/BF00397471.
Huss-Danell, K., Sellstedt, A., Flower-Ellis, A., & Sjöström, M. (1982). Ammonium effects on function and structure of nitrogen-fixing root nodules of Alnus incana (L.) Moench. Planta, 156(4), 332-40. https://doi.org/10.1007/BF00397471
Huss-Danell, K, et al. "Ammonium effects on function and structure of nitrogen-fixing root nodules of Alnus incana (L.) Moench." Planta vol. 156,4 (1982): 332-40. doi: https://doi.org/10.1007/BF00397471
Huss-Danell K, Sellstedt A, Flower-Ellis A, Sjöström M. Ammonium effects on function and structure of nitrogen-fixing root nodules of Alnus incana (L.) Moench. Planta. 1982 Dec;156(4):332-40. doi: 10.1007/BF00397471. PMID: 24272578.
Copy Download .nbib Format: NLM
Acetylene reduction, H2 evolution and (15)N 2 fixation in the Alnus incana-Frankia symbiosis.

Planta

Sellstedt A.
PMID: 24240308
Planta. 1986 Mar;167(3):382-6. doi: 10.1007/BF00391343.

Acetylene reduction, (15)N2 reduction and H2 evolution were measured in root systems of intact plants of grey alder (Alnus incana (L.) Moench) in symbiosis with Frankia. The ratios of C2H2: (15)N2 were compared with C2H2:N2 ratios calculated from C2H2...

Cite
Sellstedt A. Acetylene reduction, H2 evolution and (15)N 2 fixation in the Alnus incana-Frankia symbiosis. Planta. 1986;167(3):382-6doi: 10.1007/BF00391343.
Sellstedt, A. (1986). Acetylene reduction, H2 evolution and (15)N 2 fixation in the Alnus incana-Frankia symbiosis. Planta, 167(3), 382-6. https://doi.org/10.1007/BF00391343
Sellstedt, A. "Acetylene reduction, H2 evolution and (15)N 2 fixation in the Alnus incana-Frankia symbiosis." Planta vol. 167,3 (1986): 382-6. doi: https://doi.org/10.1007/BF00391343
Sellstedt A. Acetylene reduction, H2 evolution and (15)N 2 fixation in the Alnus incana-Frankia symbiosis. Planta. 1986 Mar;167(3):382-6. doi: 10.1007/BF00391343. PMID: 24240308.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 41 entries